Last reviewed · How we verify
Bryophyllum p.
Bryophyllum pinnatum extract promotes wound healing and tissue regeneration through anti-inflammatory and hemostatic properties.
Bryophyllum pinnatum extract promotes wound healing and tissue regeneration through anti-inflammatory and hemostatic properties. Used for Minor wounds and skin injuries, Inflammatory skin conditions, Wound healing support.
At a glance
| Generic name | Bryophyllum p. |
|---|---|
| Sponsor | Weleda AG |
| Drug class | Herbal/botanical preparation |
| Modality | Small molecule |
| Therapeutic area | Dermatology; Wound Care |
| Phase | FDA-approved |
Mechanism of action
Bryophyllum pinnatum (air plant) contains bioactive compounds including flavonoids and organic acids that reduce inflammation and support the body's natural healing processes. The preparation is used in traditional and anthroposophic medicine to enhance tissue repair and promote hemostasis in minor wounds and inflammatory conditions.
Approved indications
- Minor wounds and skin injuries
- Inflammatory skin conditions
- Wound healing support
Common side effects
- Skin irritation
- Allergic reactions
Key clinical trials
- Bryophyllum vs. Nifedipine (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bryophyllum p. CI brief — competitive landscape report
- Bryophyllum p. updates RSS · CI watch RSS
- Weleda AG portfolio CI